ArriVent BioPharma (NASDAQ:AVBP) Sets New 1-Year Low at $19.19

ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $19.19 and last traded at $19.40, with a volume of 23502 shares changing hands. The stock had previously closed at $19.88. Analysts Set New Price Targets A number of equities […]

Related Keywords

Arrivent Biopharma ,Citigroup ,Goldman Sachs Group ,Arrivent Biopharma Inc ,Arrivent Biopharma Company Profile ,Nasdaq ,Orbimed Advisors Llc ,Securities Exchange Commission ,Jefferies Financial Group ,Get Free Report ,Financial Group ,Director Orbimed Advisors Llc ,Hillhouse Investment Managemen ,Exchange Commission ,Vent Biopharma ,Arrivent Biopharma Daily ,Nasdaq Avbp ,Avbp ,Medical ,Stocks ,Technicals ,